Skip to content

4Accepted Mar 6, 6:24 PM ET

Birznieks Gunther 4

VNDAVanda Pharmaceuticals Inc.

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

6:24 PM

Mar 6, 2023

Filed

Mar 6, 2023

Documents

1

Size

7.7 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.